Published: 22:32 - 10/11/2025 Author: Lê Đình Luyến 11:43 12/11/2025 Views: 1

🤖 AI Translation Notice: This article was automatically translated by AI from the official Vietnamese publication of the School of Preventive Medicine and Public Health (HMU). For official legal/administrative reference, please consult the original Vietnamese version →.

Health Technology Assessment in Policy Decision-Making: A Case Study on the Treatment of ALK+ Non-Small Cell Lung Cancer with Ceritinib in Vietnam

🔗 Share article:

Related Articles

• ● Wellcome Trust Grant – “Infectious Disease Clinical Trial Award: Optimising Interventions for Impact” (05/12/2026)
• ● INTRODUCTION TO THE SPECIAL ISSUE OF THE SCHOOL OF PREVENTIVE MEDICINE AND PUBLIC HEALTH ON THE JOURNAL OF PREVENTIVE MEDICINE_ AUGUST 2026 (10/08/2026)
• ● SUMMARY OF SCIENTIFIC RESEARCH AND INTERNATIONAL COOPERATION ACTIVITIES IN 2025 (07/08/2026)
• ● Grant Information for July 2026 (07/08/2026)
• ● Introduction to the Global Infectious Disease Research Training Program (NIH Fogarty – PAR-24-174) (24/06/2026)
• ● International workshop: Community health workers in the context of climate change and emerging crises (09/06/2026)
• ● SPONSORSHIP AND COOPERATION PROGRAMS OF VINIF FUND IN 2026 (13/04/2026)
• ● Information about Grant in March 2026 (27/03/2026)